Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Tricia Elliott MD, FAAFP
Tricia C. Elliott MD, FAAFP Associate Editor
Dipesh Navsaria MPH, MSLIS, MD
Dipesh Navsaria MPH, MSLIS, MD Advisory Board
Irene Hamrick MD, FAAFP, AGSF, CMD
Irene Hamrick MD, FAAFP, AGSF, CMD Advisory Board
See All Experts
Published in Primary Care and
1 other channel

Journal Scan / Review · August 31, 2024

Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation

JAMA Cardiology

 

 Save  Recommend
 Share

Additional Info

JAMA Cardiology
Dose Reduction of Edoxaban in Patients 80 Years and Older With Atrial Fibrillation: Post Hoc Analysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial
JAMA Cardiol 2024 Jul 10;[EPub Ahead of Print], A Zimerman, E Braunwald, J Steffel, NM Van Mieghem, MG Palazzolo, SA Murphy, CZL Chen, M Unverdorben, CT Ruff, EM Antman, RP Giugliano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated